CFAP97D1

gene
On this page

Summary

CFAP97D1 (CFAP97 domain containing 1, HGNC:37241) is a protein-coding gene on chromosome 17q21.31, encoding Sperm axonemal maintenance protein CFAP97D1 (B2RV13). Required for male fertility through its role in axonemal doublet stabilization which is essential for sperm motility and fertilization.

Predicted to be involved in sperm axoneme assembly.

Source: NCBI Gene 284067 — RefSeq curated summary.

At a glance

  • GWAS associations: 14
  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_001136483

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37241
Approved symbolCFAP97D1
NameCFAP97 domain containing 1
Location17q21.31
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000231256
Ensembl biotypeprotein_coding
OMIM619866
Entrez284067

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay

ENST00000449302, ENST00000590148

RefSeq mRNA: 2 — MANE Select: NM_001136483 NM_001136483, NM_001353400

CCDS: CCDS45695

Canonical transcript exons

ENST00000449302 — 6 exons

ExonStartEnd
ENSE000016024014378383743783893
ENSE000016427194378111943781189
ENSE000016617574378318043783303
ENSE000017907604378043543780586
ENSE000018058094378177443781892
ENSE000027770274378438343787620

Expression profiles

Bgee: expression breadth broad, 43 present calls, max score 95.08.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1014 / max 81.1953, expressed in 4 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1610890.10144

Top tissues by expression

193 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001995.08gold quality
right testisUBERON:000453491.98gold quality
left testisUBERON:000453391.86gold quality
testisUBERON:000047387.95gold quality
adult organismUBERON:000702377.78gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047374.85gold quality
sural nerveUBERON:001548858.63silver quality
lower lobe of lungUBERON:000894954.57silver quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
epithelial cell of pancreasCL:000008353.60gold quality
upper arm skinUBERON:000426353.52gold quality
pancreatic ductal cellCL:000207951.37silver quality
myocardiumUBERON:000234950.25gold quality
ileal mucosaUBERON:000033149.89silver quality
tibialis anteriorUBERON:000138549.06silver quality
deltoidUBERON:000147648.08gold quality
leukocyteCL:000073847.42silver quality
monocyteCL:000057647.36silver quality
nasal cavity epitheliumUBERON:000538447.03gold quality
cortical plateUBERON:000534346.66gold quality
quadriceps femorisUBERON:000137746.41gold quality
skeletal muscle tissueUBERON:000113445.53silver quality
vastus lateralisUBERON:000137945.50gold quality
prefrontal cortexUBERON:000045145.13gold quality
layer of synovial tissueUBERON:000761643.55gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
cauda epididymisUBERON:000436043.12gold quality
secondary oocyteCL:000065542.57gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.90

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

16 targeting CFAP97D1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-627-3P99.9071.423316
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-430799.8270.453374
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-56799.6368.571219
HSA-MIR-4711-3P98.9766.871020
HSA-MIR-3189-5P97.5566.71655
HSA-MIR-3157-5P97.4167.61998
HSA-MIR-5699-5P97.3667.031014
HSA-MIR-64397.3567.91805
HSA-MIR-103B95.5166.85441
HSA-MIR-432393.9363.89656

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCfap97d1ENSMUSG00000010841
rattus_norvegicusCfap97d1ENSRNOG00000036796

Protein

Protein identifiers

Sperm axonemal maintenance protein CFAP97D1B2RV13 (reviewed: B2RV13)

Alternative names: CFAP97 domain-containing protein 1

All UniProt accessions (2): B2RV13, K7ER76

UniProt curated annotations — full annotation on UniProt →

Function. Required for male fertility through its role in axonemal doublet stabilization which is essential for sperm motility and fertilization.

Tissue specificity. Expressed exclusively in testis.

Similarity. Belongs to the CFAP97 family.

RefSeq proteins (2): NP_001129955, NP_001340329 (=MANE)

Domains & families (InterPro)

IDNameType
IPR029488Hmw/CFAP97Family
IPR038792CFAP97D1/2Family

Pfam: PF13879

UniProt features (2 total): chain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-B2RV13-F184.800.49

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 42 (showing top): GOBP_MALE_GAMETE_GENERATION, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_MICROTUBULE_BUNDLE_FORMATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_AXONEME_ASSEMBLY, GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION, ZNF664_TARGET_GENES, MIR627_3P, MIR4307

GO Biological Process (1): sperm axoneme assembly (GO:0007288)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
developmental process involved in reproduction1
axoneme assembly1
sperm flagellum assembly1
binding1

Protein interactions and networks

STRING

1234 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CFAP97D1C17orf50Q8WW18691
CFAP97D1C5orf52A6NGY3610
CFAP97D1SPMAP1A8MV24582
CFAP97D1SPEM2Q0P670580
CFAP97D1AXDND1Q5T1B0543
CFAP97D1ENTPD6O75354542
CFAP97D1MRPL34Q9BQ48531
CFAP97D1TMEM42Q69YG0512
CFAP97D1CCDC24Q8N4L8478
CFAP97D1TLCD5Q6ZRR5475
CFAP97D1SPMIP9Q96LM6474
CFAP97D1CCDC116Q8IYX3447
CFAP97D1KRTAP9-7A8MTY7446
CFAP97D1TBC1D3KA0A087X1G2446
CFAP97D1FBXW12Q6X9E4439

IntAct

6 interactions, top by confidence:

ABTypeScore
CFAP97D1BCL6psi-mi:“MI:0915”(physical association)0.560
CFAP97D1PPIBpsi-mi:“MI:0915”(physical association)0.400
CFAP97D1TPM2psi-mi:“MI:0914”(association)0.350
BCL6CFAP97D1psi-mi:“MI:0915”(physical association)0.000

BioGRID (13): CST6 (Affinity Capture-MS), ACADVL (Affinity Capture-MS), CALML3 (Affinity Capture-MS), S100A2 (Affinity Capture-MS), TPM2 (Affinity Capture-MS), CALML3 (Affinity Capture-MS), S100A2 (Affinity Capture-MS), CST6 (Affinity Capture-MS), C17orf105 (Two-hybrid), PPIB (Proximity Label-MS), C17orf105 (Negative Genetic), NOLC1 (Cross-Linking-MS (XL-MS)), C17orf105 (Protein-peptide)

ESM2 similar proteins: A0A1B0GU71, A6QPI4, B2RV13, D4A6L0, E1BBQ2, F1LQY6, G3UW36, O08856, P15382, P53801, P55199, P56182, Q08CB3, Q0VF94, Q148E1, Q17RQ9, Q2KJ58, Q32Q90, Q4R5F9, Q4V8A6, Q4VA36, Q5I0I4, Q5NVI6, Q5R8Q2, Q5T6X4, Q5T848, Q5XII8, Q68EN5, Q6P767, Q8C419, Q8CHT6, Q8R143, Q8R1T1, Q8TBN0, Q8VDV3, Q8WUX9, Q90YH8, Q91WM6, Q91ZP9, Q96IL0

Diamond homologs: A0A1B0GU71, B2RV13, G3UW36, Q9DAN9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

782 predictions. Top by Δscore:

VariantEffectΔscore
17:43781890:G:GTdonor_gain1.0000
17:43781890:GAG:Gdonor_gain1.0000
17:43781892:GGTAA:Gdonor_loss1.0000
17:43781893:GTAAT:Gdonor_loss1.0000
17:43781894:T:Adonor_loss1.0000
17:43784371:A:AGacceptor_gain1.0000
17:43784371:ACT:Aacceptor_gain1.0000
17:43784372:C:Gacceptor_gain1.0000
17:43784373:T:Aacceptor_gain1.0000
17:43784381:A:Gacceptor_gain1.0000
17:43780551:GCCAC:Gdonor_gain0.9900
17:43780583:ATAG:Adonor_loss0.9900
17:43780587:GT:Gdonor_loss0.9900
17:43781772:A:AGacceptor_gain0.9900
17:43781772:AG:Aacceptor_gain0.9900
17:43781773:G:GGacceptor_gain0.9900
17:43781773:GG:Gacceptor_gain0.9900
17:43781773:GGGT:Gacceptor_gain0.9900
17:43781893:G:GGdonor_gain0.9900
17:43783835:A:Gacceptor_gain0.9900
17:43784380:A:AGacceptor_gain0.9900
17:43784380:AAG:Aacceptor_gain0.9900
17:43780555:C:CGdonor_gain0.9800
17:43780582:AATAG:Adonor_gain0.9800
17:43781770:CCAG:Cacceptor_loss0.9800
17:43781771:CAG:Cacceptor_loss0.9800
17:43781862:T:TAdonor_gain0.9800
17:43781863:G:GAdonor_gain0.9800
17:43783301:C:Tdonor_gain0.9800
17:43783759:A:Gacceptor_gain0.9800

AlphaMissense

1094 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:43781820:T:CL81P0.958
17:43783840:T:CS148P0.956
17:43783203:G:CR113P0.946
17:43781834:G:CA86P0.945
17:43783231:C:AN122K0.927
17:43783231:C:GN122K0.927
17:43783229:A:GN122D0.925
17:43783242:T:CL126P0.923
17:43781812:C:AN78K0.920
17:43781812:C:GN78K0.920
17:43783233:A:CQ123P0.920
17:43781840:G:CA88P0.915
17:43783251:T:CL129P0.915
17:43783209:T:CL115P0.910
17:43781131:T:AV46D0.902
17:43781866:T:AD96E0.892
17:43781866:T:GD96E0.892
17:43783298:T:AW145R0.886
17:43783298:T:CW145R0.886
17:43783230:A:CN122T0.878
17:43783300:G:CW145C0.873
17:43783300:G:TW145C0.873
17:43783230:A:TN122I0.869
17:43781832:T:GI85S0.867
17:43781869:C:GC97W0.861
17:43783229:A:CN122H0.861
17:43781867:T:CC97R0.859
17:43783230:A:GN122S0.858
17:43781864:G:CD96H0.857
17:43781810:A:GN78D0.853

dbSNP variants (sampled 300 via entrez): RS1000602014 (17:43778777 C>A,T), RS1000972813 (17:43778936 G>A,T), RS1001088813 (17:43779011 G>A,C,T), RS1001236686 (17:43778873 C>T), RS1001251253 (17:43784691 G>T), RS1001648136 (17:43781830 A>T), RS1001790932 (17:43779344 C>T), RS1002250814 (17:43780259 A>G), RS1002858277 (17:43787071 A>G), RS1002910075 (17:43786857 T>C), RS1002912329 (17:43783056 C>T), RS1003355694 (17:43782872 T>G), RS1003371397 (17:43781153 G>A,T), RS1004443983 (17:43780412 T>A,C), RS1004534527 (17:43785128 C>T)

Disease associations

OMIM: gene MIM:619866 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

14 associations (top):

StudyTraitp-value
GCST008070_25HDL cholesterol levels2.000000e-10
GCST008070_90HDL cholesterol levels9.000000e-09
GCST008074_103Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)8.000000e-20
GCST008074_48Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)5.000000e-21
GCST008075_153HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)9.000000e-34
GCST008075_18HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)7.000000e-31
GCST008083_149Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)7.000000e-21
GCST008083_85Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)1.000000e-22
GCST008084_154HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)1.000000e-41
GCST008084_30HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)3.000000e-36
GCST008085_143HDL cholesterol levels in current drinkers4.000000e-12
GCST008085_22HDL cholesterol levels in current drinkers2.000000e-13
GCST008087_23Triglyceride levels in current drinkers2.000000e-08
GCST008087_97Triglyceride levels in current drinkers2.000000e-07

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004612high density lipoprotein cholesterol measurement
EFO:0004530triglyceride measurement
EFO:0004329alcohol drinking

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Faffects cotreatment, increases methylation1
tebuconazoledecreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
Fulvestrantaffects cotreatment, increases methylation1
Catechinaffects cotreatment, increases expression1
Leadincreases expression1
Methotrexateincreases expression1
Tretinoindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.